Growing evidence suggests that stroke alters the phenotype of the peripheral immune system; better characterization of this response could provide new insights into stroke pathophysiology. In this investigation, we employed a deconvolution approach to informatically infer the cellular composition of the circulating leukocyte pool at multiple timepoints following stroke onset based on whole blood mRNA expression. Microarray data generated from the peripheral blood of 23 cardiovascular disease controls and 23 ischemic stroke patients at 3, 5, and 24 hours post-symptom onset were obtained from a public repository. Transcriptomic deconvolution was used to estimate the relative counts of nine leukocyte populations based on the expression of cell-specific transcripts, and cell counts were compared between groups across timepoints. Inferred counts of lymphoid cell populations including B-cells, CD4+ T-cells, CD8+ T-cells, γδ T-cells, and NK-cells were significantly lower in stroke samples relative to control samples. With respect to myeloid cell populations, inferred counts of neutrophils and monocytes were significantly higher in stroke samples compared to control samples, however inferred counts of eosinophils and dendritic cells were significantly lower. These collective differences were most dramatic in samples collected at 5 and 24 hours post-symptom onset. Findings were subsequently confirmed in a second dataset generated from an independent population of 24 controls and 39 ischemic stroke patients. Collectively, these results offer a comprehensive picture of the early stroke-induced changes to the complexion of the circulating leukocyte pool, and provide some of the first evidence that stroke triggers an acute decrease in eosinophil counts.
Introduction
It is becoming increasingly evident that the peripheral immune system responds robustly to stroke, and that this response influences clinical outcome. Several prior studies have performed genome-wide transcriptomic profiling of peripheral whole blood with the goal of identifying clinically-useful stroke biomarkers [2] [3] [4] [5] [6] . Recent work by our group suggests that similar to other conditions [7] , several of the gene expression changes observed between stroke patients and controls in these investigations were likely artifacts of underlying changes in leukocyte counts, and not true changes in transcription at the cellular level [8, 9] . Transcriptomic deconvolution is a process which leverages such phenomena to informatically infer the cellular composition of complex biological samples based on aggregate gene expression through the analysis of cell-specific transcripts [10] . In this study, in an attempt to better characterize the stroke-induced peripheral immune response, we employed a deconvolution approach to infer the counts of nine major circulating leukocyte populations at multiple timepoints following stroke onset using publicly available human whole blood gene expression data.
ANALYSIS OF EARLY STROKE-INDUCED CHANGES IN CIRCULATING LEUKOCYTE COUNTS USING TRANSCRIPTOMIC DECONVOLUTION Methods

Microarray data processing
Raw microarray data generated from the peripheral whole blood of 23 controls, as well as Weighted correlation network analysis was used to produce a relative count for each cell population based on the expression levels of its associated genes using the collapserows() function of the 'WGCNA' package according to the method described by Miller et al. [12] . Relative counts of each cell population were arbitrarily scaled from zero to one using unitybased normalization.
Demographic information
Clinical and demographic information associated with samples was aggregated from the descriptors reported in Stamnova et al. [13] .
Statistics
All statistics were performed using R 3.3.
Fisher's exact test was used for comparison of dichotomous variables. T-test or oneway ANOVA was used for comparisons of continuous variables where appropriate. The null hypothesis was rejected when p<0.05.
Validation of results
Findings were subsequently confirmed via deconvolution of a second publically available microarray dataset generated from an independent population of 24 controls and 39 ischemic stroke patients (GEO accession number GSE16561) [14] .
Results
Clinical and demographic characteristics
Stroke samples originated from patients which were significantly older than control counterparts, but were well matched in terms of sex and ethnicity. In terms of risk factors for cardiovascular disease, groups were well matched with regards to rates of hypertension and diabetes, however control subjects displayed a significantly higher prevalence of dyslipidemia relative to stroke patients. All stroke patients had received thrombolytic intervention via recombinant tissue plasminogen activator (rtPA) following 3 hour blood collection (Table 1) .
Inferred leukocyte counts T-cell counts in stroke; one reporting that γδ T-cell counts are elevated [19] , one reporting that they are unaffected [20] , and one reporting that they are decreased [21] . Our results provide additional evidence suggesting that stroke triggers an acute decrease in circulating γδ T-cell numbers similar to that which is observed in other lymphoid populations.
Our results are also consistent with those of several prior cytometry-based investigations reporting that counts of the two most abundant peripheral blood myeloid cell populations, neutrophils and monocytes, become robustly elevated in response to stroke [15, 17, 22, 23] .
However, our findings also suggest that two lesser-studied myeloid populations, dendritic cells and eosinophils, are significantly reduced.
With respect to dendritic cells, our observations are consistent with those reported in the limited number of prior cytometric studies performed in humans [24] . With respect to eosinophils, this current study is one of the first case-control analyses to report evidence of an acute reduction in eosinophil counts in response to stroke; our observations align well with two recent associative studies reporting Translational Neuroscience Figure 1 . Cell-specific genes used for deconvolution. 226 cell-specific genes used for the deconvolution of whole blood microarray data along with their predominant leukocyte population of expression. trophils, eosinophils, and dendritic cells in blood sampled from controls and stroke patients at 3, 5, and 24 hours post symptom onset. Counts were statistically compared between stroke and control samples across time points using one-way ANOVA with subsequent planned comparisons via Bonferoni-corrected two-sample two-tailed t-test. 
